Artificial intelligence (AI) and machine learning (ML) are ushering in a new era in drug discovery. The AlphaFold2 system developed by Google’s Deepmind was able to predict the 3D structures of over 200 million proteins - with accuracy on par with experimental methods - in just two years. AI tools are being combined into virtual screening platforms that can accelerate multiple steps in the drug discovery process.

*Reprinted with permission. February 21, 2024